<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Vulvar lichen sclerosus: Clinical manifestations and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Vulvar lichen sclerosus: Clinical manifestations and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Vulvar lichen sclerosus: Clinical manifestations and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephanie J Arnold, FACD, MBBS (Hons), BSc (Hons)
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Inge M Kreuser-Genis, MBChB, MRCP (Derm)
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert L Barbieri, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey Callen, MD, FACP, FAAD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Abena O Ofori, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jul 11, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lichen sclerosus (LS) is a benign, chronic, progressive, dermatologic condition characterized by marked inflammation, epithelial thinning, and distinctive dermal changes that may be accompanied by symptoms of pruritus or pain  (
         <a class="graphic graphic_picture graphicRef78574 graphicRef62753 graphicRef59461" href="/z/d/graphic/78574.html" rel="external">
          picture 1A-C
         </a>
         ). LS usually occurs in the anogenital region but can develop on any skin surface. Vulvar LS is the most common clinical presentation.
        </p>
        <p>
         The clinical manifestations and diagnosis of vulvar LS will be reviewed here. The management of vulvar LS is reviewed separately. Extragenital LS and LS involving the penis are also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/141056.html" rel="external">
          "Vulvar lichen sclerosus: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/15838.html" rel="external">
          "Extragenital lichen sclerosus: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/140876.html" rel="external">
          "Extragenital lichen sclerosus: Management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6876.html" rel="external">
          "Balanitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1918672849">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The previous designation for LS was "lichen sclerosus et atrophicus." Use of the "et atrophicus" ceased because it implied the condition was only atrophic, whereas areas of thickening and hyperplasia often occur. (See
         <a class="local">
          'Clinical manifestations and natural history'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvar LS is one of the most common conditions treated in vulvar clinics. The true prevalence is unknown. Estimates range from 1 in 30 older adult females, to 1 in 59 females in a general gynecology practice, to 1 in 300 to 1000 patients referred to dermatologists [
         <a href="#rid1">
          1-5
         </a>
         ].
        </p>
        <p>
         Vulvar LS can occur at any age but tends to have two peaks of onset: the prepubertal period and the perimenopausal to postmenopausal period [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
         The incidence of vulvar LS may be rising [
         <a href="#rid7">
          7,8
         </a>
         ]. A population-based study in Finland found an increase in the age-adjusted incidence of LS from 14 per 100,000 woman-years in 2003 to 22 per 100,000 woman-years in 2010 to 2012 [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology of LS is unknown and is likely to be multifactorial. Several mechanisms have been proposed:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic factors
         </strong>
         – Familial aggregations of LS among fathers and daughters, mothers and daughters, sisters, and twins (identical and fraternal) have been reported [
         <a href="#rid6">
          6,9,10
         </a>
         ]. A study that compared two unrelated families with vulvar LS using whole-exome sequencing found germline variants in four genes, including two related to neutrophil and macrophage function [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Immunologic abnormality
         </strong>
         – Disorders of the immune system are more common among patients with LS, suggesting that autoimmune mechanisms and immune dysregulation may be involved in the etiology of the disease [
         <a href="#rid12">
          12-20
         </a>
         ]. For example:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         LS has been associated with autoimmune diseases, such as alopecia areata, vitiligo, thyroid disorders, pernicious anemia, and diabetes mellitus. In addition, a few cases of concomitant LS and celiac disease have been published [
         <a href="#rid21">
          21,22
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         In a series of 350 female adults and children with histologically confirmed LS (of which 98 percent had vulvar disease), 22 percent had an autoimmune disorder, and 42 percent had one or more autoantibodies (antithyroid, antigastric parietal cell, antinuclear, antismooth muscle, or antimitochondrial antibodies) with titers greater than 1:20 [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         A case-control study of 190 adult females with vulvar LS and 922 female controls found an increased likelihood of autoimmune disorders among patients with vulvar LS (28 versus 9 percent) [
         <a href="#rid20">
          20
         </a>
         ]. However, an increase in the prevalence of a similar panel of autoantibodies was not detected.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An analysis of antibody profiles of 86 individuals with LS and 85 healthy controls found an increased level of antibody formation against extracellular matrix protein 1 (a key component of the dermis) in 74 percent of females with LS [
         <a href="#rid24">
          24
         </a>
         ]. The relevance of this finding to disease pathogenesis requires further investigation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Microribonucleic acids (miRNAs) are small ribonucleic acid (RNA) molecules that regulate cell processes by targeting the 3' untranslated region of target messenger ribonucleic acid (mRNA) to influence gene expression. A study comparing miRNA expression in lesional skin versus adjacent normal skin samples of 33 patients with LS found differences in the expression of several miRNAs related to autoimmunity [
         <a href="#rid8">
          8
         </a>
         ]. These differences could also be observed in blood samples from patients with LS compared with healthy volunteers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hormonal factors
         </strong>
         – The highest incidence of vulvar LS is observed during low-estrogen physiologic states, such as the premenarchal and the postmenopausal periods [
         <a href="#rid23">
          23
         </a>
         ], suggesting a hormonal influence on the pathogenesis of the disease. Although there may be a negative association between progesterone-only forms of contraception and LS, systematic reviews have not found evidence to support the efficacy of topical application of
         <a class="drug drug_general" data-topicid="9817" href="/z/d/drug information/9817.html" rel="external">
          progesterone
         </a>
         nor of hormone replacement therapy [
         <a href="#rid25">
          25,26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/141056.html" rel="external">
          "Vulvar lichen sclerosus: Management", section on 'Topical progesterone and topical testosterone'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Androgen levels do not appear to be related to LS. An early, poorly designed study noted that patients with vulvar LS have decreased serum levels of dihydrotestosterone, free
         <a class="drug drug_general" data-topicid="9981" href="/z/d/drug information/9981.html" rel="external">
          testosterone
         </a>
         , and androstenedione compared with age-matched controls without the disease [
         <a href="#rid27">
          27
         </a>
         ]. However, many subsequent studies have not confirmed these findings, and testosterone is not an effective treatment for the disease. (See
         <a class="medical medical_review" href="/z/d/html/141056.html" rel="external">
          "Vulvar lichen sclerosus: Management", section on 'Topical progesterone and topical testosterone'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection
         </strong>
         – Infectious agents (eg,
         <em>
          Borrelia burgdorferi
         </em>
         , variably acid-fast bacteria, human papillomavirus [HPV]) have been postulated to induce LS [
         <a href="#rid28">
          28-32
         </a>
         ], but no clear relationship has been demonstrated [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cell kinetics
         </strong>
         – An elastase-type enzyme produced by vulvar fibroblasts may lead to the destruction of connective tissue in patients with LS [
         <a href="#rid34">
          34
         </a>
         ]. Despite this destruction, there appears to be active regeneration with significant collagen synthesis [
         <a href="#rid35">
          35
         </a>
         ]. In a study of keratin differentiation markers using specific monoclonal antibodies, keratins 6 and 16 were associated with increased cell turnover in LS, consistent with a hyperproliferative state [
         <a href="#rid36">
          36
         </a>
         ]. This was confirmed in another study using flow cytometry analysis [
         <a href="#rid37">
          37
         </a>
         ]. The clinical significance of these findings has not been established.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Vulvar skin affected by LS has a wide range of proliferative capacity [
         <a href="#rid38">
          38
         </a>
         ]. Proliferation markers, as well as the tumor suppressor p53, are upregulated in genital LS, perhaps reflecting increased levels of oxidative stress [
         <a href="#rid38">
          38,39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          External factors
         </strong>
         – The reason for the higher frequency of LS involving the vulvar area compared with LS in other body sites is unknown. Exposure of susceptible skin to urine has been proposed as a contributing factor to vulvar LS; however, data are insufficient to confirm a contributory effect. In a study of a vulval dermatology database that assessed data from 126 adult females with vulvar LS and 258 adult females without vulvar LS, patients with LS were more likely to have documented urinary incontinence (63 versus 34 percent) [
         <a href="#rid40">
          40
         </a>
         ]. Other studies suggest a role for urine exposure in genital LS in males [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The Koebner phenomenon (ie, the development of isomorphic pathologic lesions in the traumatized, uninvolved skin of patients who have a cutaneous disease) can occur in patients with LS [
         <a href="#rid42">
          42
         </a>
         ]. Trauma, injury, and sexual abuse may trigger symptoms.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          CLINICAL MANIFESTATIONS AND NATURAL HISTORY
         </span>
         <span class="headingEndMark">
          —
         </span>
         LS usually occurs in the anogenital region (85 to 98 percent of LS cases) but can develop on any skin surface [
         <a href="#rid43">
          43,44
         </a>
         ]. A subset of patients with vulvar LS also has extragenital LS. (See
         <a class="local">
          'Other sites of involvement'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2899545521">
         <span class="h2">
          Symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pruritus and soreness or irritation are the most common symptoms. Vulvar LS may also be asymptomatic.
        </p>
        <p>
         The major symptoms are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vulvar pruritus
         </strong>
         – Vulvar pruritus occurs in most patients and is often so intense that it interferes with sleep. Pruritus is not specific to LS, as pruritus is a feature of most vulvar disorders  (
         <a class="graphic graphic_table graphicRef55449" href="/z/d/graphic/55449.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anal discomfort
         </strong>
         – Patients with vulvar LS may also have involvement of perianal skin  (
         <a class="graphic graphic_picture graphicRef62753 graphicRef59461" href="/z/d/graphic/62753.html" rel="external">
          picture 1B-C
         </a>
         ). Common symptoms include pruritus ani, painful defecation, anal fissures, and rectal bleeding. In children, constipation may be a presenting symptom [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dyspareunia
         </strong>
         – Dyspareunia and other forms of sexual dysfunction are common in patients with LS and may significantly impact a patient's quality of life [
         <a href="#rid46">
          46
         </a>
         ]. Sexual dysfunction may occur due to inflammatory disease or as a late symptom if associated with introital stenosis, fissures, or posterior deflection of fused labial tissues at the time of intromission. Fusion over the clitoris can also cause diminished sexual sensation or even anorgasmia, although this is uncommon. Marked dyspareunia may occur in perimenopausal or postmenopausal females with estrogen deficiency in addition to vulvar LS.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A questionnaire-based study that examined patients' views of their sexual problems following the diagnosis of vulvar LS found that the majority of 45 sexually active respondents described detrimental effects on sexual function, including dyspareunia, apareunia, and difficulty achieving orgasm [
         <a href="#rid47">
          47
         </a>
         ]. These symptoms appeared to be due to continuing inflammation and anatomic changes and scarring from long-standing, active disease. Other studies have quantified the effect of LS on sexual function using the Female Sexual Function Index and have found a significant impact across a range of domains, including desire, arousal, lubrication, orgasm, satisfaction, and pain [
         <a href="#rid48">
          48,49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dysuria
         </strong>
         – Dysuria and difficulty voiding can occur, especially when there is fusion of the labia minora over the urethra with advanced disease.
        </p>
        <p>
        </p>
        <p>
         In asymptomatic patients, LS is detected by careful inspection of the vulva for the characteristic thin, white, wrinkled skin and changes in vulvar architecture. For example, there may be loss of portions or all of the labia minora, and the clitoris may become buried under the fused prepuce. (See
         <a class="local">
          'Physical findings'
         </a>
         below and
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Physical findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physical findings of vulvar LS include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atrophy, hypopigmentation, and other lesions
         </strong>
         – Classic vulvar LS presents as white, atrophic papules and macules that may coalesce into plaques; follicular plugging may be observed in early lesions. LS can also be hemorrhagic, purpuric, hyperkeratotic, bullous, eroded, or ulcerated [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The lesions most frequently affect the labia minora and/or labia majora  (
         <a class="graphic graphic_picture graphicRef78574 graphicRef98770" href="/z/d/graphic/78574.html" rel="external">
          picture 1A, 1D
         </a>
         ). However, the whitening may extend to involve the clitoris as well as over the perineum and around the anus in a keyhole fashion  (
         <a class="graphic graphic_picture graphicRef62753 graphicRef59461" href="/z/d/graphic/62753.html" rel="external">
          picture 1B-C
         </a>
         ). Extension onto the genitocrural folds or buttocks may also occur [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Fissuring is frequently seen at the posterior fourchette, perianally, in the interlabial folds, or around the clitoris. The introitus may have a yellow, waxy appearance. Fordyce spots (small, raised papules along the inner aspect of the labia minora, which represent normal sebaceous glands) disappear.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Scratching may result in excoriations and secondary, mild lichenification (thickening of the epidermis with exaggeration of normal skin lines), often associated with edema of the labia minora and the prepuce  (
         <a class="graphic graphic_picture graphicRef72766" href="/z/d/graphic/72766.html" rel="external">
          picture 2
         </a>
         ). Relatively minor rubbing or intercourse may lead to hemorrhage and/or petechiae with purpura and ecchymoses due to the fragility of the involved skin  (
         <a class="graphic graphic_picture graphicRef75883 graphicRef80900" href="/z/d/graphic/75883.html" rel="external">
          picture 3A-B
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Loss of vulvar architecture
         </strong>
         – The vulvar architecture remains intact early in the disease  (
         <a class="graphic graphic_picture graphicRef60960" href="/z/d/graphic/60960.html" rel="external">
          picture 4
         </a>
         ). As the disease progresses, the distinction between the labia majora and minora is lost, and the clitoris becomes buried under the fused prepuce  (
         <a class="graphic graphic_picture graphicRef57562 graphicRef54149 graphicRef70014" href="/z/d/graphic/57562.html" rel="external">
          picture 5A-C
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Shrinkage of the introitus and perineum causes dyspareunia and more fissuring upon intercourse or insertion of a speculum. End-stage LS may progress to show a pale and featureless vulva due to midline fusion, with only a small "pinhole" posterior orifice.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H954830644">
         <span class="h2">
          Other sites of involvement
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with vulvar LS may have associated extragenital or vaginal involvement:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Extragenital lichen sclerosus
         </strong>
         – Extragenital LS may be present in patients with vulvar LS. Extragenital lesions present as macules, papules, or atrophic plaques [
         <a href="#rid44">
          44
         </a>
         ]. Although lesions have been described as characteristically white in color, lesions in patients with highly pigmented skin may demonstrate hyperpigmentation or hypopigmentation rather than a white color  (
         <a class="graphic graphic_picture graphicRef79867 graphicRef51592" href="/z/d/graphic/79867.html" rel="external">
          picture 6A-B
         </a>
         ) [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The most common sites for extragenital LS include the thighs, breasts, wrists, shoulders, neck, back, and, rarely, the oral cavity [
         <a href="#rid53">
          53
         </a>
         ]. The distribution is often symmetrical. Unlike vulvar LS, extragenital LS is usually asymptomatic and does not appear to carry the same risk of malignant transformation. (See
         <a class="medical medical_review" href="/z/d/html/15838.html" rel="external">
          "Extragenital lichen sclerosus: Clinical features and diagnosis"
         </a>
         and
         <a class="local">
          'Association with malignancy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vaginal lichen sclerosus
         </strong>
         – Although vaginal involvement traditionally has not been considered a feature of LS, a few cases of combined vulvar and vaginal LS have been reported [
         <a href="#rid54">
          54,55
         </a>
         ]. These cases appear to be due to prolapse of the vagina resulting in squamatization. Additional studies are necessary to clarify the prevalence of vaginal LS. Unlike vulvar LS, there are no reported cases of vaginal LS resulting in vaginal squamous cell carcinoma (SCC). Cervical LS does not occur. (See
         <a class="local">
          'Association with malignancy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H2176847047">
         <span class="h2">
          General approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         Often, a diagnosis of vulvar LS can be made based upon recognizing characteristic clinical manifestations (white, atrophic plaques in combination with fissures, ecchymoses, and anatomical changes). When necessary, a biopsy and histopathologic examination can be performed to confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H2728411578">
         <span class="h2">
          Role of biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Not all cases of vulvar LS require a confirmatory biopsy [
         <a href="#rid51">
          51,56
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to biopsy in adults
         </strong>
         – In our practice, we do not biopsy adult patients who have the typical features of vulvar LS, particularly if photography (with appropriate patient consent) is available to clearly document the clinical findings at the time of diagnosis. However, a biopsy is helpful in the following scenarios:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Confirming an uncertain diagnosis
         </strong>
         – A biopsy is indicated when the diagnosis is uncertain (eg, patients presenting with atypical features). We are also more likely to perform a biopsy when patients present with possible LS during their reproductive years because vulval pallor can occur in vulval dermatitis, which is a more likely diagnosis in this age group.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In general, a pretreatment biopsy is preferred because the typical histologic findings of LS are less evident after treatment with topical or intralesional corticosteroids. Therefore, if there is any level of uncertainty about the diagnosis, early performance of a biopsy is prudent.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Re-evaluating the diagnosis after initial treatment fails
         </strong>
         . (See
         <a class="medical medical_review" href="/z/d/html/141056.html" rel="external">
          "Vulvar lichen sclerosus: Management", section on 'Failure of initial therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Assessing for concomitant malignancy in patients with suggestive clinical findings
         </strong>
         . (See
         <a class="local">
          'Association with malignancy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to biopsy in children
         </strong>
         – In children, a vulvar LS diagnosis is often based only on the clinical examination. Biopsy is reserved for children with atypical clinical features or treatment-refractory disease and often requires general anesthetic (given the site and discomfort) [
         <a href="#rid57">
          57,58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Biopsy technique
         </strong>
         – A 4 mm vulvar punch biopsy typically provides sufficient tissue to confirm the diagnosis and to evaluate for atypical histologic features. (See
         <a class="medical medical_review" href="/z/d/html/5577.html" rel="external">
          "Skin biopsy techniques", section on 'Punch biopsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interpretation of biopsy findings
         </strong>
         – On histopathologic examination, the epidermis is typically thinned (accounting for the older nomenclature "lichen sclerosus et atrophicus"), although areas of hyperkeratosis may be observed  (
         <a class="graphic graphic_picture graphicRef58841" href="/z/d/graphic/58841.html" rel="external">
          picture 7
         </a>
         ), and early lesions may demonstrate mild, irregular epidermal acanthosis [
         <a href="#rid59">
          59
         </a>
         ]. The upper dermis exhibits homogenization of collagen, with a band of lymphocytes below this region. The characteristic histologic findings may be absent if the biopsy misses an area of active pathology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Clinical judgment should guide the diagnosis and treatment of LS when biopsy results are not specific. For example, when clinical signs that strongly suggest vulvar LS (eg, local pruritus plus depigmentation or loss of vulvar architecture) are present in conjunction with inconclusive biopsy results, we proceed with treatment for LS. Clinicopathologic correlation with a dermatopathologist can be helpful.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Additional evaluation
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment for extragenital lichen sclerosus
         </strong>
         – A subset of patients with vulvar LS have associated extragenital LS. Performing a full skin examination aids with identifying patients with other sites of LS. (See
         <a class="local">
          'Other sites of involvement'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment for autoimmune disease
         </strong>
         – Since disorders of the immune system are more common among patients with LS, a review of systems should be performed. When clinical signs or symptoms suggestive of autoimmune disease are evident, we select additional diagnostic studies based upon the suspected autoimmune disease (eg, thyroid disease, diabetes, pernicious anemia). (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recognition of concomitant infection
         </strong>
         – Clinicians must also remain alert to the possibility of coexisting bacterial or fungal vulvar infections. Investigative studies (eg, microscopy or culture) to diagnose infection should be performed if signs suggestive of vulvar or vaginal infection are present. Some patients may have higher risk for concomitant infection, such as patients with diabetes. (See
         <a class="medical medical_review" href="/z/d/html/5477.html" rel="external">
          "Vaginitis in adults: Initial evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5452.html" rel="external">
          "Candida vulvovaginitis: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/134115.html" rel="external">
          "Vulvovaginitis in the prepubertal child: Clinical manifestations, diagnosis, and treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Various other disorders may be confused with vulvar LS. Broader descriptions of the differential diagnoses for vulvar lesions are provided separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/128407.html" rel="external">
          "Vulvar lesions: Differential diagnosis of white lesions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5412.html" rel="external">
          "Vulvar lesions: Differential diagnosis of vesicles, bullae, erosions, and ulcers"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/128406.html" rel="external">
          "Vulvar lesions: Differential diagnosis of red lesions"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6450.html" rel="external">
          "Overview of vulvovaginal conditions in the prepubertal child"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         LS and vulvar lichen planus share several common features and may occur together on the vulva (termed "lichen sclerosus/lichen planus" overlap) [
         <a href="#rid60">
          60
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vulvar lichen planus
         </strong>
         – Potential findings of vulvar lichen planus include painful erosions with white striae on the mucosa (erosive lichen planus); pruritic, violaceous papules or plaques on the vulva (papulosquamous lichen planus); or hyperkeratotic plaques on the perineum (hypertrophic lichen planus)  (
         <a class="graphic graphic_picture graphicRef96571 graphicRef62561" href="/z/d/graphic/96571.html" rel="external">
          picture 8A-B
         </a>
         ). Both lichen planus and LS can produce intense pruritus, discomfort (particularly in the erosive subtype of lichen planus), and loss of vulvar architecture  (
         <a class="graphic graphic_picture graphicRef96570" href="/z/d/graphic/96570.html" rel="external">
          picture 9
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In contrast to LS, erosive lichen planus usually also involves the vagina (inflammation and synechiae). A punch biopsy can be helpful for the diagnosis of lichen planus, especially when reviewed by a dermatopathologist, but the histologic findings may resemble findings in LS. (See
         <a class="medical medical_review" href="/z/d/html/5557.html" rel="external">
          "Vulvar lichen planus"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Examples of disorders that may also present with hypopigmentation on the vulva include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vitiligo
         </strong>
         – Vitiligo produces depigmented patches on the skin  (
         <a class="graphic graphic_picture graphicRef98768 graphicRef80058" href="/z/d/graphic/98768.html" rel="external">
          picture 10A-B
         </a>
         ). Other LS features, such as atrophy, fissuring, hemorrhagic lesions, and hypertrophic lesions, are absent. Vitiligo can be confused with LS if other manifestations of LS are minimal. Vitiligo can usually be diagnosed based on the physical findings. The coexistence of vitiligo and vulvar LS has been reported [
         <a href="#rid20">
          20,61
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/105109.html" rel="external">
          "Vitiligo: Pathogenesis, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Examples of disorders that may also present with atrophy, erosions, or pain on the vulva include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anal fissures
         </strong>
         – LS with anal involvement can cause painful perianal fissuring and bleeding, and these symptoms can be confused with anal fissures. However, anal fissures are tears of the anal canal, whereas fissures caused by LS are found in the perianal skin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Chronic anal fissures may present with anal pain and raised edges, exposing white, horizontal fibers of the internal anal sphincter muscles  (
         <a class="graphic graphic_picture graphicRef51583" href="/z/d/graphic/51583.html" rel="external">
          picture 11
         </a>
         ). In contrast, cutaneous findings of perianal LS are more extensive, and fissuring is limited to the perianal skin  (
         <a class="graphic graphic_picture graphicRef62753 graphicRef59461" href="/z/d/graphic/62753.html" rel="external">
          picture 1B-C
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/2543.html" rel="external">
          "Anal fissure: Clinical manifestations, diagnosis, prevention"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mucous membrane pemphigoid
         </strong>
         – Mucous membrane pemphigoid (MMP), an uncommon immunobullous disease that presents with mucosal inflammation and erosions, should enter the differential diagnosis, particularly if there is marked labial adhesion  (
         <a class="graphic graphic_picture graphicRef75723" href="/z/d/graphic/75723.html" rel="external">
          picture 12
         </a>
         ). Associated oral or ocular erosions may be present.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Biopsies are necessary for the diagnosis of MMP. In addition to a biopsy of lesional tissue for routine histopathologic examination, a fresh tissue sample should be taken from an adjacent, normal area of skin for direct immunofluorescence. (See
         <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">
          "Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid", section on 'Clinical features of mucous membrane pemphigoid'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Vulvovaginal atrophy
         </strong>
         – Estrogen deficiency secondary to menopause or premature ovarian failure can lead to a thinned (atrophic) epidermis, labial adhesion, and dyspareunia  (
         <a class="graphic graphic_picture graphicRef54086" href="/z/d/graphic/54086.html" rel="external">
          picture 13
         </a>
         ). These changes should begin to respond to topical estrogen within four to six weeks. Failure of a response after 12 weeks should prompt a vulvar biopsy to exclude LS. Vulvovaginal atrophy and LS can coexist. (See
         <a class="medical medical_review" href="/z/d/html/5464.html" rel="external">
          "Genitourinary syndrome of menopause (vulvovaginal atrophy): Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5443.html" rel="external">
          "Genitourinary syndrome of menopause (vulvovaginal atrophy): Treatment"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Labial adhesions due to low estrogen can also occur in prepubertal females. (See
         <a class="medical medical_review" href="/z/d/html/6450.html" rel="external">
          "Overview of vulvovaginal conditions in the prepubertal child", section on 'Labial adhesions'
         </a>
         .)
        </p>
        <p>
         Examples of disorders that may also present with thickened or inflamed vulvar skin include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          <em>
           Candida
          </em>
         </strong>
         <strong>
          vulvovaginitis
         </strong>
         –
         <strong>
         </strong>
         Like vulvar LS, vulvovaginal candidiasis can present with chronic vulvar itching or burning  (
         <a class="graphic graphic_picture graphicRef98769" href="/z/d/graphic/98769.html" rel="external">
          picture 14
         </a>
         ) [
         <a href="#rid62">
          62
         </a>
         ]. If feasible, a wet mount can be performed to look for hyphae. If the wet mount is negative, then culture may be helpful.
         <em>
          Candida
         </em>
         vulvovaginitis is common and can coexist with LS. (See
         <a class="medical medical_review" href="/z/d/html/5452.html" rel="external">
          "Candida vulvovaginitis: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endogenous and exogenous dermatitis
         </strong>
         – Dermatitis (eczema) of the vulva generally presents as vulvar pruritus and irritation, and clinical findings can range from diffuse erythema, scale, and fissuring to thick lichenification. The labia majora are commonly affected.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although the etiology classically has been divided into endogenous types of dermatitis (eg, seborrheic dermatitis and atopic dermatitis) and exogenous dermatitis (eg, irritant contact dermatitis and allergic contact dermatitis), the cause is frequently multifactorial. Signs of atopic or seborrheic dermatitis are usually observed elsewhere on the skin. Dermatitis may be indistinguishable from early LS, in which case biopsy is indicated. (See
         <a class="medical medical_review" href="/z/d/html/5563.html" rel="external">
          "Vulvar dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lichen simplex chronicus
         </strong>
         – Lichen simplex chronicus does not denote a specific disease entity but describes a non-neoplastic, morphologic alteration of vulvar skin related to chronic irritation  (
         <a class="graphic graphic_picture graphicRef59195" href="/z/d/graphic/59195.html" rel="external">
          picture 15
         </a>
         ). The vulvar skin appears thickened (lichenified) and may be erythematous, hypopigmented, or hyperpigmented.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Lichen simplex chronicus is diagnosed when anatomic and clinical findings have excluded specific causes of hyperplastic epithelial changes, such as LS, psoriasis, lichen planus, eczema, seborrheic dermatitis, human papillomavirus (HPV) infection, and
         <em>
          Candida
         </em>
         infection. If the diagnosis remains uncertain, a biopsy can be helpful. The histopathology consists of irregular thickening of the Malpighian layer of rete ridges (acanthosis), hyperkeratosis, and parakeratosis with a mid-dermal inflammatory infiltrate. (See
         <a class="medical medical_review" href="/z/d/html/128406.html" rel="external">
          "Vulvar lesions: Differential diagnosis of red lesions", section on 'Lichen simplex chronicus'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psoriasis
         </strong>
         – Psoriasis can occur in genital locations and is pruritic, but it usually appears with inflamed, well-demarcated plaques  (
         <a class="graphic graphic_picture graphicRef56110 graphicRef126362" href="/z/d/graphic/56110.html" rel="external">
          picture 16A-B
         </a>
         ). The recognition of psoriasis involving other sites of the body can be helpful for diagnosis. Occasionally, a biopsy is needed. (See
         <a class="medical medical_review" href="/z/d/html/5664.html" rel="external">
          "Psoriasis: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          ASSOCIATION WITH MALIGNANCY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vulvar LS is associated with an increased risk for vulvar squamous cell carcinoma (SCC). Reports of other malignancies in sites of LS are rare. (See
         <a class="local">
          'Squamous cell carcinoma'
         </a>
         below and
         <a class="local">
          'Other skin cancers'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1935476538">
         <span class="h2">
          Squamous cell carcinoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adults with vulvar LS are at a slightly increased risk of developing squamous cell carcinoma (SCC) of the vulva  (
         <a class="graphic graphic_picture graphicRef71222 graphicRef50192" href="/z/d/graphic/71222.html" rel="external">
          picture 17A-B
         </a>
         ) [
         <a href="#rid2">
          2,7,44,63-65
         </a>
         ]. Also, evidence of concomitant vulvar LS is not uncommon in patients with vulvar SCC [
         <a href="#rid66">
          66-68
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk estimates
         </strong>
         – Although the risk of vulvar SCC in patients with vulvar LS is increased, this risk is estimated to be less than 5 percent [
         <a href="#rid51">
          51,69
         </a>
         ]. Examples of studies that have assessed risk include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a retrospective cohort study of 3038 patients with diagnoses of vulvar LS entered in a Dutch pathology registry between 1991 and 2011, 75 of 2875 females (3 percent) who did not already have a diagnosis of vulvar SCC made close to the time of the vulvar LS diagnosis subsequently developed vulvar SCC [
         <a href="#rid7">
          7
         </a>
         ]. The median time to diagnosis of vulvar SCC was 3.3 years (range 0.27 to 18.4 years) after the diagnosis of vulvar LS.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In an Italian, retrospective study of 976 females with vulvar LS followed for 1 to 331 months (median follow-up of 52 months), 34 (3.5 percent) subsequently received a diagnosis of vulvar neoplasia (vulvar intraepithelial neoplasia or invasive SCC) [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A retrospective cohort study in northern Italy compared the incidence of vulvar cancer in females with histologically proven LS versus all females in the reference population (approximately 185,000 females) over 16 years using cancer registry data and found an overall incidence of 2.76 cases of vulvar cancer per 1000 patient-years [
         <a href="#rid71">
          71
         </a>
         ]. Furthermore, vulvar LS accounted for 98 percent of the attributable risk on the incidence of vulvar cancer in this cohort.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         It is unclear whether there is an increased risk for vulvar SCC in children with this disease, but it is thought to be unlikely [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Reports of SCC in sites of extragenital LS are rare [
         <a href="#rid72">
          72
         </a>
         ]. However, males with penile LS may have an increased risk of penile SCC. (See
         <a class="medical medical_review" href="/z/d/html/140876.html" rel="external">
          "Extragenital lichen sclerosus: Management", section on 'Prognosis and follow-up'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6876.html" rel="external">
          "Balanitis in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Proposed risk modifiers
         </strong>
         – Distinguishing cases of LS with a high likelihood of evolving into SCC is an active area of investigation [
         <a href="#rid73">
          73
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Age and vulvar intraepithelial neoplasia
         </strong>
         – The retrospective cohort study of 3038 patients diagnosed with vulvar LS between 1991 and 2011 in a Dutch pathology registry found a higher incidence rate of vulvar SCC cancer development in females with LS who had concurrent vulvar intraepithelial neoplasia or were aged ≥70 years old at the time of diagnosis [
         <a href="#rid7">
          7
         </a>
         ]. Differentiated vulvar intraepithelial neoplasia is a precursor to SCC and is often associated with LS  (
         <a class="graphic graphic_picture graphicRef54596" href="/z/d/graphic/54596.html" rel="external">
          picture 18
         </a>
         ) but not human papillomavirus (HPV) infection. Usual type vulvar intraepithelial neoplasia, also a premalignant lesion, is mediated by HPV but is less likely to be associated with LS. (See
         <a class="medical medical_review" href="/z/d/html/3237.html" rel="external">
          "Vulvar cancer: Epidemiology, diagnosis, histopathology, and treatment", section on 'Risk factors and etiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Interferon regulatory factor 6
         </strong>
         – A study that compared expression of the interferon regulatory factor 6 (
         <em>
          IRF6
         </em>
         ) tumor suppressor gene in specimens of vulvar SCC with adjacent vulvar LS, cancer-free vulvar LS, and normal skin from a total of 60 females found that dysregulation of the
         <em>
          IRF6
         </em>
         gene via methylation of the
         <em>
          IRF6
         </em>
         promoter may play a role in the development of vulvar SCC in vulvar LS [
         <a href="#rid74">
          74
         </a>
         ]. Further study is necessary to determine whether methylation of the
         <em>
          IRF6
         </em>
         promoter is a useful marker of cancer risk.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Disease status and management
         </strong>
         – Further study is necessary to clarify the impact of disease status (eg, duration) and management on risk for SCC. The level of adherence to topical corticosteroid treatment is a proposed modifying factor:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         A prospective cohort study of 507 female adults with vulvar LS followed over six years compared females who reported adherence to treatment (use of maintenance corticosteroids as directed all or most of the time) versus those who reported less adherence to treatment (use of maintenance topical corticosteroids as directed some, little, or none of the time). There was a statistically significant inverse association between treatment adherence and the risk of vulvar neoplasia (0 cases among 357 females in the adherent group versus 4 differentiated vulvar intraepithelial neoplasias and 3 invasive SCCs among 150 females in the nonadherent group [4.7 percent]) [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2047714156">
         <span class="h2">
          Other skin cancers
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are case reports of melanoma, basal cell carcinoma, and Merkel cell carcinoma with LS, but a relationship between LS and these cancers has not been established [
         <a href="#rid51">
          51
         </a>
         ]. There are rare reports of vulvar melanoma developing in association with vulvar LS in adults and children [
         <a href="#rid76">
          76
         </a>
         ]. Penile melanoma in males with genital LS has been reported [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1630120824">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118665.html" rel="external">
          "Society guideline links: Lichen sclerosus"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/83960.html" rel="external">
          "Patient education: Lichen sclerosus (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/8413.html" rel="external">
          "Patient education: Vulvar lichen sclerosus (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Lichen sclerosus (LS) refers to a benign, chronic, progressive, dermatologic condition characterized by marked inflammation, epithelial thinning, and distinctive dermal changes that are often accompanied by pruritus and pain. LS usually occurs in the anogenital region but can develop on any skin surface in adults and children  (
         <a class="graphic graphic_picture graphicRef78574 graphicRef62753" href="/z/d/graphic/78574.html" rel="external">
          picture 1A-B
         </a>
         ). (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/15838.html" rel="external">
          "Extragenital lichen sclerosus: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical manifestations
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Mucocutaneous findings
         </strong>
         – The classic appearance is thin, white, wrinkled skin localized to the labia minora and/or labia majora  (
         <a class="graphic graphic_picture graphicRef78574 graphicRef98770" href="/z/d/graphic/78574.html" rel="external">
          picture 1A, 1D
         </a>
         ), although the whitening may extend over the perineum and around the anus in a keyhole fashion  (
         <a class="graphic graphic_picture graphicRef62753" href="/z/d/graphic/62753.html" rel="external">
          picture 1B
         </a>
         ). Areas of epithelial hyperplasia from chronic rubbing are often seen. Fissuring is frequently present perianally, in the interlabial folds, or around the clitoris. At the end stages, the vulva is pallid and featureless due to midline fusion. (See
         <a class="local">
          'Physical findings'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Symptoms
         </strong>
         – Vulvar pruritus is a common symptom of vulvar LS and can be so intense that it interferes with sleep. Other symptoms include pruritus ani, painful defecation, rectal bleeding, dyspareunia, and dysuria. However, some patients are asymptomatic. (See
         <a class="local">
          'Symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of vulvar LS can often be made based on the recognition of characteristic clinical manifestations. When the diagnosis is uncertain, a skin biopsy can be helpful for confirming the diagnosis. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Association with malignancy
         </strong>
         – There is a slightly increased risk of squamous cell carcinoma (SCC) of the vulva in patients with LS. Adequate treatment of the disease may be associated with a reduced risk of development of neoplasia. (See
         <a class="local">
          'Association with malignancy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H436570671">
         <span class="h1">
          ACKNOWLEDGMENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Elizabeth G Stewart, MD, and Susan M Cooper, MB ChB, MRCGP, FRCP, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Jones RW, Scurry J, Neill S, MacLean AB. Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics. Am J Obstet Gynecol 2008; 198:496.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace HJ. Lichen sclerosus et atrophicus. Trans St Johns Hosp Dermatol Soc 1971; 57:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer GO. The commonest causes of symptomatic vulvar disease: a dermatologist's perspective. Australas J Dermatol 1996; 37:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldstein AT, Marinoff SC, Christopher K, Srodon M. Prevalence of vulvar lichen sclerosus in a general gynecology practice. J Reprod Med 2005; 50:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leibovitz A, Kaplun V V, Saposhnicov N, Habot B. Vulvovaginal examinations in elderly nursing home women residents. Arch Gerontol Geriatr 2000; 31:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell J, Wojnarowska F. Childhood vulvar lichen sclerosus: an increasingly common problem. J Am Acad Dermatol 2001; 44:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bleeker MC, Visser PJ, Overbeek LI, et al. Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 2016; 25:1224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halonen P, Jakobsson M, Heikinheimo O, et al. Incidence of lichen sclerosus and subsequent causes of death: a nationwide Finnish register study. BJOG 2020; 127:814.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyrick Thomas RH, Kennedy CT. The development of lichen sclerosus et atrophicus in monozygotic twin girls. Br J Dermatol 1986; 114:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox NH, Mitchell JN, Morley WN. Lichen sclerosus et atrophicus in non-identical female twins. Br J Dermatol 1986; 115:743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haefner HK, Welch KC, Rolston AM, et al. Genomic Profiling of Vulvar Lichen Sclerosus Patients Shows Possible Pathogenetic Disease Mechanisms. J Low Genit Tract Dis 2019; 23:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan I, Oyama N, Neill SM, et al. Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Clin Exp Dermatol 2004; 29:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oyama N, Chan I, Neill SM, et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus. J Clin Invest 2004; 113:1550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Purcell KG, Spencer LV, Simpson PM, et al. HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol 1990; 126:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marren P, Millard PR, Wojnarowska F. Vulval lichen sclerosus: Lack of correlation between duration of clinical symptoms and histological appearances. J Eur Acad Dermatol Venereol 1997; 8:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carli P, Cattaneo A, Pimpinelli N, et al. Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus. Dermatologica 1991; 182:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scrimin F, Rustja S, Radillo O, et al. Vulvar lichen sclerosus: an immunologic study. Obstet Gynecol 2000; 95:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol 2005; 84:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cooper SM, Ali I, Baldo M, Wojnarowska F. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study. Arch Dermatol 2008; 144:1432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs L, Gilliam A, Khavari N, Bass D. Association between lichen sclerosus and celiac disease: a report of three pediatric cases. Pediatr Dermatol 2014; 31:e128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karadag AS, Kavala M, Ozlu E, et al. The co-occurrence of lichen sclerosus et atrophicus and celiac disease. Indian Dermatol Online J 2014; 5:S106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyrick Thomas RH, Ridley CM, McGibbon DH, Black MM. Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women. Br J Dermatol 1988; 118:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oyama N, Chan I, Neill SM, et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Higgins CA, Cruickshank ME. A population-based case-control study of aetiological factors associated with vulval lichen sclerosus. J Obstet Gynaecol 2012; 32:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chi CC, Kirtschig G, Baldo M, et al. Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. J Am Acad Dermatol 2012; 67:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Friedrich EG Jr, Kalra PS. Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone. N Engl J Med 1984; 310:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cantwell AR Jr. Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus. Int J Dermatol 1984; 23:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alonso-Llamazares J, Persing DH, Anda P, et al. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review. Acta Derm Venereol 1997; 77:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiene P, Milde-Langosch K, Löning T. Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus. Arch Dermatol Res 1991; 283:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drut RM, Gómez MA, Drut R, Lojo MM. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol 1998; 15:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisendle K, Grabner T, Kutzner H, Zelger B. Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus. Arch Dermatol 2008; 144:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farrell AM, Millard P, Wojnaroska F. An infective aetiology for lichen sclerosus: Myth or reality. Br J Dermatol 1997; 137:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Godeau G, Frances C, Hornebeck W, et al. Isolation and partial characterization of an elastase-type protease in human vulva fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus. J Invest Dermatol 1982; 78:270.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oikarinen A, Sandberg M, Hurskainen T, et al. Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques. Acta Derm Venereol Suppl (Stockh) 1991; 162:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staughn RC, Neill SM, Lane EB, Leigh IM. The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus. Br J Dermatol 1990; 123:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lessana-Leibowitch M, Poot M, Rizk-Rabin M, et al. Flow cytometric analysis of lichen sclerosus compared with normal vulvar skin and carcinoma in situ. Eur J Dermatol 1992; 2:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soini Y, Pääkkö P, Vähäkangas K, et al. Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features. Int J Gynecol Pathol 1994; 13:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan SH, Derrick E, McKee PH, et al. Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus. J Cutan Pathol 1994; 21:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirby L, Gran S, Orekoya F, et al. Is urinary incontinence associated with vulval lichen sclerosus in women? A cross-sectional study. Br J Dermatol 2021; 185:1063.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kravvas G, Muneer A, Watchorn RE, et al. Male genital lichen sclerosus, microincontinence and occlusion: mapping the disease across the prepuce. Clin Exp Dermatol 2022; 47:1124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Todd P, Halpern S, Kirby J, Pembroke A. Lichen sclerosus and the Köbner phenomenon. Clin Exp Dermatol 1994; 19:262.
          </a>
         </li>
         <li class="breakAll">
          Ridley CM, Neill SM. Non-infective cutaneous conditions of the vulva. In: The Vulva, Ridley CM, Neill SM (Eds), Blackwell Science, 1999. p.121.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas RH, Ridley CM, McGibbon DH, Black MM. Anogenital lichen sclerosus in women. J R Soc Med 1996; 89:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lagerstedt M, Karvinen K, Joki-Erkkilä M, et al. Childhood lichen sclerosus--a challenge for clinicians. Pediatr Dermatol 2013; 30:444.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haefner HK, Aldrich NZ, Dalton VK, et al. The impact of vulvar lichen sclerosus on sexual dysfunction. J Womens Health (Larchmt) 2014; 23:765.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dalziel KL. Effect of lichen sclerosus on sexual function and parturition. J Reprod Med 1995; 40:351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van de Nieuwenhof HP, Meeuwis KA, Nieboer TE, et al. The effect of vulvar lichen sclerosus on quality of life and sexual functioning. J Psychosom Obstet Gynaecol 2010; 31:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gutierrez-Ontalvilla P, Botella R, Iborra M, et al. The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus. Eur J Dermatol 2019; 29:430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Funaro D. Lichen sclerosus: a review and practical approach. Dermatol Ther 2004; 17:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis FM, Tatnall FM, Velangi SS, et al. British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018. Br J Dermatol 2018; 178:839.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Farris DR, Hardy D, Kagen MH, et al. Extragenital pigmented lichen sclerosus. J Eur Acad Dermatol Venereol 2000; 14:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353:1777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longinotti M, Schieffer YM, Kaufman RH. Lichen sclerosus involving the vagina. Obstet Gynecol 2005; 106:1217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zendell K, Edwards L. Lichen sclerosus with vaginal involvement: report of 2 cases and review of the literature. JAMA Dermatol 2013; 149:1199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirtschig G, Becker K, Günthert A, et al. Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus. J Eur Acad Dermatol Venereol 2015; 29:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bercaw-Pratt JL, Boardman LA, Simms-Cendan JS, North American Society for Pediatric and Adolescent Gynecology. Clinical recommendation: pediatric lichen sclerosus. J Pediatr Adolesc Gynecol 2014; 27:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dendrinos ML, Quint EH. Lichen sclerosus in children and adolescents. Curr Opin Obstet Gynecol 2013; 25:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Regauer S, Liegl B, Reich O. Early vulvar lichen sclerosus: a histopathological challenge. Histopathology 2005; 47:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lessani T, Gallego H, Lynch PJ. Lichen planus and lichen sclerosus overlap. Cutis 1998; 61:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weisberg EL, Le LQ, Cohen JB. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis. Int J Dermatol 2008; 47:1053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nyirjesy P. Lichen Sclerosus and Other Conditions Mimicking Vulvovaginal Candidiasis. Curr Infect Dis Rep 2002; 4:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carli P, Cattaneo A, De Magnis A, et al. Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study. Eur J Cancer Prev 1995; 4:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leibowitch M, Neill S, Pelisse M, Moyal-Baracco M. The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women. Br J Obstet Gynaecol 1990; 97:1135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zaki I, Dalziel KL, Solomonsz FA, Stevens A. The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exp Dermatol 1996; 21:334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walkden V, Chia Y, Wojnarowska F. The association of squamous cell carcinoma of the vulva and lichen sclerosus: implications for management and follow up. J Obstet Gynaecol 1997; 17:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vilmer C, Cavelier-Balloy B, Nogues C, et al. Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases. Eur J Gynaecol Oncol 1998; 19:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006; 30:310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vieira-Baptista P, Pérez-López FR, López-Baena MT, et al. Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review. J Low Genit Tract Dis 2022; 26:250.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Micheletti L, Preti M, Radici G, et al. Vulvar Lichen Sclerosus and Neoplastic Transformation: A Retrospective Study of 976 Cases. J Low Genit Tract Dis 2016; 20:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corazza M, Borghi A, Gafà R, et al. Risk of vulvar carcinoma in women affected with lichen sclerosus: results of a cohort study. J Dtsch Dermatol Ges 2019; 17:1069.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sergeant A, Vernall N, Mackintosh LJ, et al. Squamous cell carcinoma arising in extragenital lichen sclerosus. Clin Exp Dermatol 2009; 34:e278.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raspollini MR, Asirelli G, Moncini D, Taddei GL. A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma. Am J Obstet Gynecol 2007; 197:592.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rotondo JC, Borghi A, Selvatici R, et al. Hypermethylation-Induced Inactivation of the IRF6 Gene as a Possible Early Event in Progression of Vulvar Squamous Cell Carcinoma Associated With Lichen Sclerosus. JAMA Dermatol 2016; 152:928.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee A, Bradford J, Fischer G. Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women. JAMA Dermatol 2015; 151:1061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hieta N, Kurki S, Rintala M, et al. Association of Vulvar Melanoma with Lichen Sclerosus. Acta Derm Venereol 2019; 99:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turnbull N, Shim T, Patel N, et al. Primary Melanoma of the Penis in 3 Patients With Lichen Sclerosus. JAMA Dermatol 2016; 152:226.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5558 Version 29.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17905173" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Guidelines for the follow-up of women with vulvar lichen sclerosus in specialist clinics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5570266" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8936065" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The commonest causes of symptomatic vulvar disease: a dermatologist's perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16130842" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Prevalence of vulvar lichen sclerosus in a general gynecology practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10989157" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Vulvovaginal examinations in elderly nursing home women residents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11312428" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Childhood vulvar lichen sclerosus: an increasingly common problem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27257093" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32065721" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Incidence of lichen sclerosus and subsequent causes of death: a nationwide Finnish register study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3954957" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The development of lichen sclerosus et atrophicus in monozygotic twin girls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3801314" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Lichen sclerosus et atrophicus in non-identical female twins.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31232912" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Genomic Profiling of Vulvar Lichen Sclerosus Patients Shows Possible Pathogenetic Disease Mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15347336" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Characterization of IgG autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15173881" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7888355" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : The association between lichen sclerosus and antigens of the HLA system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2200345" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : HLA antigens in lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Vulval lichen sclerosus: Lack of correlation between duration of clinical symptoms and histological appearances
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2013351" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Immunohistochemical evidence of skin immune system involvement in vulvar lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10636518" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Vulvar lichen sclerosus: an immunologic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15819407" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Immune dysregulation in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19015417" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25382799" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Association between lichen sclerosus and celiac disease: a report of three pediatric cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25593796" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The co-occurrence of lichen sclerosus et atrophicus and celiac disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3342175" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Lichen sclerosus et atrophicus and autoimmunity--a study of 350 women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12867112" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Autoantibodies to extracellular matrix protein 1 in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22369403" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : A population-based case-control study of aetiological factors associated with vulval lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22483994" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6537989" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Serum levels of sex hormones in vulvar lichen sclerosus, and the effect of topical testosterone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6724767" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Histologic observations of pleomorphic, variably acid-fast bacteria in scleroderma, morphea, and lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9228224" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1666278" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Human papillomavirus infection in vulvar lesions of lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9572688" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18490585" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Possible role of Borrelia burgdorferi sensu lato infection in lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : An infective aetiology for lichen sclerosus: Myth or reality
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6917873" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Isolation and partial characterization of an elastase-type protease in human vulva fibroblasts: its possible involvement in vulvar elastic tissue destruction of patients with lichen sclerosus et atrophicus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1771996" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Collagen biosynthesis in lichen sclerosus et atrophicus studied by biochemical and in situ hybridization techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The cytokeratin profile of normal vulval epithelium and vulval lichen sclerosus
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Flow cytometric analysis of lichen sclerosus compared with normal vulvar skin and carcinoma in situ
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7928051" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Expression of p53 and proliferating cell nuclear antigen in lichen sclerosus et atrophicus with different histological features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7798388" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Altered p53 expression and epidermal cell proliferation is seen in vulval lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34128542" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Is urinary incontinence associated with vulval lichen sclerosus in women? A cross-sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35150005" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Male genital lichen sclerosus, microincontinence and occlusion: mapping the disease across the prepuce.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8033394" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Lichen sclerosus and the Köbner phenomenon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8033394" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Lichen sclerosus and the Köbner phenomenon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9014881" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Anogenital lichen sclerosus in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23437870" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Childhood lichen sclerosus--a challenge for clinicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25162790" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The impact of vulvar lichen sclerosus on sexual dysfunction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7608874" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Effect of lichen sclerosus on sexual function and parturition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20701461" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The effect of vulvar lichen sclerosus on quality of life and sexual functioning.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31625922" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14756888" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Lichen sclerosus: a review and practical approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29313888" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11204533" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Extragenital pigmented lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10348006" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16260578" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Lichen sclerosus involving the vagina.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23925660" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Lichen sclerosus with vaginal involvement: report of 2 cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26202852" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Evidence-based (S3) Guideline on (anogenital) Lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24602304" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Clinical recommendation: pediatric lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23812382" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Lichen sclerosus in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16178888" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Early vulvar lichen sclerosus: a histopathological challenge.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9515220" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Lichen planus and lichen sclerosus overlap.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18986354" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12433328" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Lichen Sclerosus and Other Conditions Mimicking Vulvovaginal Candidiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8580785" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Squamous cell carcinoma arising in vulval lichen sclerosus: a longitudinal cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2177649" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : The epithelial changes associated with squamous cell carcinoma of the vulva: a review of the clinical, histological and viral findings in 78 women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9136150" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : The under-reporting of skin disease in association with squamous cell carcinoma of the vulva.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15511956" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The association of squamous cell carcinoma of the vulva and lichen sclerosus: implications for management and follow up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9476054" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Analysis of alterations adjacent to invasive vulvar carcinoma and their relationship with the associated carcinoma: a study of 67 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16538050" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35285455" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Risk of Development of Vulvar Cancer in Women With Lichen Sclerosus or Lichen Planus: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26882123" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Vulvar Lichen Sclerosus and Neoplastic Transformation: A Retrospective Study of 976 Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31631548" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Risk of vulvar carcinoma in women affected with lichen sclerosus: results of a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19438563" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Squamous cell carcinoma arising in extragenital lichen sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17714682" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : A comparative analysis of lichen sclerosus of the vulva and lichen sclerosus that evolves to vulvar squamous cell carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27223861" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Hypermethylation-Induced Inactivation of the IRF6 Gene as a Possible Early Event in Progression of Vulvar Squamous Cell Carcinoma Associated With Lichen Sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26070005" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Long-term Management of Adult Vulvar Lichen Sclerosus: A Prospective Cohort Study of 507 Women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30521058" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Association of Vulvar Melanoma with Lichen Sclerosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26536280" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Primary Melanoma of the Penis in 3 Patients With Lichen Sclerosus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
